200,000+ products from a single source!

sales@angenechem.com

Home > Amines > 70583-39-0

70583-39-0

70583-39-0 | 2,4-PTERIDINEDIAMINE, 6-[(1-NAPHTHALENYLAMINO)-METHYL]-

CAS No: 70583-39-0 Catalog No: AG005HR4 MDL No:

Product Description

Catalog Number:
AG005HR4
Chemical Name:
2,4-PTERIDINEDIAMINE, 6-[(1-NAPHTHALENYLAMINO)-METHYL]-
CAS Number:
70583-39-0
Molecular Formula:
C17H15N7
Molecular Weight:
317.3479
IUPAC Name:
6-[(naphthalen-1-ylamino)methyl]pteridine-2,4-diamine
InChI:
InChI=1S/C17H15N7/c18-15-14-16(24-17(19)23-15)21-9-11(22-14)8-20-13-7-3-5-10-4-1-2-6-12(10)13/h1-7,9,20H,8H2,(H4,18,19,21,23,24)
InChI Key:
QVHFSGMRVQZGMC-UHFFFAOYSA-N
SMILES:
Nc1nc(N)c2c(n1)ncc(n2)CNc1cccc2c1cccc2
NSC Number:
235777

Properties

Complexity:
420  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
317.139g/mol
Formal Charge:
0
Heavy Atom Count:
24  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0
Molecular Weight:
317.356g/mol
Monoisotopic Mass:
317.139g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
116A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.9  

Literature

Title Journal
Lipophilic antifolates as agents against opportunistic infections. 1. Agents superior to trimetrexate and piritrexim against Toxoplasma gondii and Pneumocystis carinii in in vitro evaluations. Journal of medicinal chemistry 19960315
New drug developments for opportunistic infections in immunosuppressed patients: Pneumocystis carinii. Journal of medicinal chemistry 19951124
Evaluation of potent inhibitors of dihydrofolate reductase in a culture model for growth of Pneumocystis carinii. Antimicrobial agents and chemotherapy 19951101
Identification of highly potent and selective inhibitors of Toxoplasma gondii dihydrofolate reductase. Antimicrobial agents and chemotherapy 19930901
Lipophilic antifolates as candidates against opportunistic infections. Advances in experimental medicine and biology 19930101
Pneumocystis carinii dihydrofolate reductase used to screen potential antipneumocystis drugs. Antimicrobial agents and chemotherapy 19910701
Inhibition of Pneumocystis dihydrofolate reductase by analogs of pyrimethamine, methotrexate and trimetrexate. The Journal of protozoology 19910101

Related Products

© 2019 Angene International Limited. All rights Reserved.